Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2264-2270

  Sanchez Tena S ^a,b   Vizan P ^a,c   Dudeja, P K ^d   Centelles, J J ^a,b   Cascante, M ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Butyrate; Colon cancer; Differentiation; Epicatechin; Epigallocatechin gallate

Indexed keywords

BUTYRIC ACID; EPICATECHIN; EPIGALLOCATECHIN GALLATE; HISTONE DEACETYLASE; MONOCARBOXYLATE TRANSPORTER 1; POLYPHENOL DERIVATIVE; TRICHOSTATIN A;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL MEMBRANE; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN INTERACTION; SUPPLEMENTATION; TEA;

EID: 84884542900     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.08.009     Document Type: Article

References (46)

1. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 2010, 19:1893-1907.
2. Watson A.J., Collins P.D. Colon cancer: a civilization disorder. Digest. Dis. (Basel, Switzerland) 2011, 29:222-228.
3. Ferguson L.R., Chavan R.R., Harris P.J. Changing concepts of dietary fiber: implications for carcinogenesis. Nutr. Cancer 2001, 39:155-169.
4. Juskiewicz J., Milala J., Jurgonski A., Krol B., Zdunczyk Z. Consumption of polyphenol concentrate with dietary fructo-oligosaccharides enhances cecal metabolism of quercetin glycosides in rats. Nutrition (Burbank Los Angeles County, Calif) 2011, 27:351-357.
5. Kosmala M., Kolodziejczyk K., Zdunczyk Z., Juskiewicz J., Boros D. Chemical composition of natural and polyphenol-free apple pomace and the effect of this dietary ingredient on intestinal fermentation and serum lipid parameters in rats. J. Agric. Food Chem. 2011, 59:9177-9185.
6. Juskiewicz J., Zary-Sikorska E., Zdunczyk Z., Krol B., Jaroslawska J., Jurgonski A. Effect of dietary supplementation with unprocessed and ethanol-extracted apple pomaces on caecal fermentation, antioxidant and blood biomarkers in rats. Br. J. Nutr. 2012, 107:1138-1146.
7. Berni Canani R., Di Costanzo M., Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin. Epigenetics 2012, 4:4.
8. Corfe B.M., Williams E.A., Bury J.P., Riley S.A., Croucher L.J., Lai D.Y., Evans C.A. A study protocol to investigate the relationship between dietary fibre intake and fermentation, colon cell turnover, global protein acetylation and early carcinogenesis: the FACT study. BMC Cancer 2009, 9:332.
9. Alcarraz-Vizan G., Boren J., Lee W.N., Cascante M. Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation. Metabolomics 2010, 6:229-237.
10. Boren J., Lee W.N., Bassilian S., Centelles J.J., Lim S., Ahmed S., Boros L.G., Cascante M. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J. Biol. Chem. 2003, 278:28395-28402.
11. Andriamihaja M., Chaumontet C., Tome D., Blachier F. Butyrate metabolism in human colon carcinoma cells: implications concerning its growth-inhibitory effect. J. Cell. Physiol. 2009, 218:58-65.
12. Shen W.J., Dai D.Q., Teng Y., Liu J. Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene. Zhonghua yi xue za zhi 2008, 88:1192-1196.
13. Humphreys K.J., Cobiac L., Le Leu R.K., Van der Hoek M.B., Michael M.Z. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Mol. Carcinog. 2013, 52:459-474.
14. Carafa V., Nebbioso A., Altucci L. Histone deacetylase inhibitors: recent insights from basic to clinical knowledge & patenting of anti-cancer actions. Recent Pat. Anticancer Drug Discov. 2011, 6:131-145.
15. Kanwar J., Taskeen M., Mohammad I., Huo C., Chan T.H., Dou Q.P. Recent advances on tea polyphenols. Front. Biosci. (Elite Ed.) 2012, 4:111-131.
16. Yang C.S., Wang X. Green tea and cancer prevention. Nutr. Cancer 2010, 62:931-937.
17. Balasubramanian S., Ecker R.L. Keratinocyte proliferation, differentiation, and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol. Appl. Pharmacol. 2007, 224:214-219.
18. Lamy S., Gingras D., Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 2002, 62:381-385.
19. Oka Y., Iwai S., Amano H., Irie Y., Yatomi K., Ryu K., Yamada S., Inagaki K., Oguchi K. Tea polyphenols inhibit rat osteoclast formation and differentiation. J. Pharmacol. Sci. 2012, 118:55-64.
20. Lea M.A., Ibeh C., Han L., Desbordes C. Inhibition of growth and induction of differentiation markers by polyphenolic molecules and histone deacetylase inhibitors in colon cancer cells. Anticancer Res. 2010, 30:311-318.
21. Gonçalves P., Araujo J.R., Pinho M.J., Martel F. In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds. Nutr. Cancer 2011, 63:282-294.
22. Moyer M.P., Manzano L.A., Merriman R.L., Stauffer J.S., Tanzer L.R. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell. Dev. Biol. 1996, 32:315-317.
23. Sanchez-Tena S., Fernandez-Cachon M.L., Carreras A., Mateos-Martin M.L., Costoya N., Moyer M.P., Nunez M.J., Torres J.L., Cascante M. Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells. J. Nat. Prod. 2012, 75:26-33.
24. Bergmeyer H.U. Standardization of enzyme assays. Clin. Chem. 1972, 18:1305-1311.
25. Qiu Y., Wang Y., Law P.Y., Chen H.Z., Loh H.H. Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts. Mol. Pharmacol. 2011, 80:210-218.
26. Zhao F., Zhang J., Liu Y.S., Li L., He Y.L. Research advances on flotillins. Virol. J. 2011, 8:479.
27. Waldecker M., Kautenburger T., Daumann H., Veeriah S., Will F., Dietrich H., Pool-Zobel B.L., Schrenk D. Histone-deacetylase inhibition and butyrate formation: fecal slurry incubations with apple pectin and apple juice extracts. Nutrition (Burbank Los Angeles County, Calif) 2008, 24:366-374.
28. Saksena S., Theegala S., Bansal N., Gill R.K., Tyagi S., Alrefai W.A., Ramaswamy K., Dudeja P.K. Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells. Am. J. Physiol. 2009, 297:G878-G885.
29. Colin D., Limagne E., Jeanningros S., Jacquel A., Lizard G., Athias A., Gambert P., Hichami A., Latruffe N., Solary E., Delmas D. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prev. Res. (Phila.) 2011, 4:1095-1106.
30. Waldecker M., Kautenburger T., Daumann H., Busch C., Schrenk D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 2008, 19:587-593.
31. Nair S., Hebbar V., Shen G., Gopalakrishnan A., Khor T.O., Yu S., Xu C., Kong A.N. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Pharm. Res. 2008, 25:387-399.
32. Amoedo N.D., Rodrigues M.F., Pezzuto P., Galina A., da Costa R.M., de Almeida F.C., El-Bacha T., Rumjanek F.D. Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors. PLoS One 2011, 6:e22264.
33. Gonçalves P., Araujo J.R., Martel F. Characterization of butyrate uptake by nontransformed intestinal epithelial cell lines. J. Membr. Biol. 2011, 240:35-46.
34. Borthakur A., Anbazhagan A.N., Kumar A., Raheja G., Singh V., Ramaswamy K., Dudeja P.K. The probiotic Lactobacillus plantarum counteracts TNF-{alpha}-induced downregulation of SMCT1 expression and function. Am. J. Physiol. 2010, 299:G928-G934.
35. Konishi Y., Kobayashi S., Shimizu M. Tea polyphenols inhibit the transport of dietary phenolic acids mediated by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. J. Agric. Food Chem. 2003, 51:7296-7302.
36. Shim C.K., Cheon E.P., Kang K.W., Seo K.S., Han H.K. Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells. J. Pharm. Pharmacol. 2007, 59:1515-1519.
37. Vaidyanathan J.B., Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 2003, 307:745-752.
38. Wang Q., Morris M.E. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab. Dispos. 2007, 35:201-208.
39. Cuff M.A., Lambert D.W., Shirazi-Beechey S.P. Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol. 2002, 539:361-371.
40. Borthakur A., Saksena S., Gill R.K., Alrefai W.A., Ramaswamy K., Dudeja P.K. Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway. J. Cell. Biochem. 2008, 103:1452-1463.
41. Chen G., Howe A.G., Xu G., Frohlich O., Klein J.D., Sands J.M. Mature N-linked glycans facilitate UT-A1 urea transporter lipid raft compartmentalization. FASEB J. 2011, 25:4531-4539.
42. Patra S.K., Rizzi F., Silva A., Rugina D.O., Bettuzzi S. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J. Physiol. Pharmacol. 2008, 59(Suppl. 9):217-235.
43. Duhon D., Bigelow R.L., Coleman D.T., Steffan J.J., Yu C., Langston W., Kevil C.G., Cardelli J.A. The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. Mol. Carcinog. 2010, 49:739-749.
44. Adachi S., Nagao T., Ingolfsson H.I., Maxfield F.R., Andersen O.S., Kopelovich L., Weinstein I.B. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 2007, 67:6493-6501.
45. Yang C.S., Lambert J.D., Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch. Toxicol. 2009, 83:11-21.
46. Ingolfsson H.I., Koeppe R.E., Andersen O.S. Effects of green tea catechins on gramicidin channel function and inferred changes in bilayer properties. FEBS Lett. 2011, 585:3101-3105.